Sanger sequencing was performed in LRRK2, PRKN, and ATXN3 in 57 Nigerian patients with PD from Yoruba, Igbo, and Edo tribes (12.3% with EOPD) but did not identify any pathogenic mutations (9). This evidence concerns the gene PRKN and Parkinson disease.